Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02124395 · ClinicalTrials.gov registry record
Health-related Quality of Life in Rare Kidney Stone
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 365
- Enrollment target
NCT02124395 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 365 participants.
The verdict
NCT02124395 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 365 participants
- Enrollment target
Study Summary
Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium
Interventions
- OTHER Health-related Quality of Life in Rare Kidney Stone Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2013-08 |
| Est. Completion | 2022-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02124395
The ClinicalTrials.gov registry entry for NCT02124395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Health-related Quality of Life in Rare Kidney Stone Questionnaire is the first listed.
NCT02124395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02124395 about?
NCT02124395 is a clinical study titled "Health-related Quality of Life in Rare Kidney Stone". Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium
What is the current status of trial NCT02124395?
This trial is currently completed. The enrollment target is 365 participants. The study started on 2013-08. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02124395?
The interventions under investigation include: Health-related Quality of Life in Rare Kidney Stone Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02124395?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.